T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
CVR Energy
CVI
$3.52B
| $944K | ﹤0.01% |
36,965
-3,785
| -9% | -$78.6K |
|
|
TBCH
2027
Turtle Beach Corp
TBCH
$230M
| $944K | ﹤0.01% |
44,340
+11,210
| +34% | +$235K |
|
2028
JFrog
FROG
$11.5B
| $941K | ﹤0.01% |
34,935
-73,834
| -68% | -$1.87M |
|
2029
Vishay Intertechnology
VSH
$5.11B
| $940K | ﹤0.01% |
47,958
+13,719
| +40% | +$276K |
|
|
CIO
2030
DELISTED
City Office REIT
CIO
| $938K | ﹤0.01% |
53,129
+969
| +2% | +$17.4K |
|
2031
Opko Health
OPK
$1.04B
| $937K | ﹤0.01% |
272,505
-12,169
| -4% | -$43K |
|
2032
Trupanion
TRUP
$1.33B
| $937K | ﹤0.01% |
10,514
+827
| +9% | +$76.1K |
|
2033
Adtran
ADTN
$665M
| $935K | ﹤0.01% |
50,698
+1,043
| +2% | +$20.7K |
|
|
DM
2034
DELISTED
Desktop Metal, Inc.
DM
| $931K | ﹤0.01% |
19,633
+1,661
| +9% | +$70.3K |
|
|
EVBG
2035
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $931K | ﹤0.01% |
21,333
+3,914
| +22% | +$185K |
|
2036
CoreCivic
CXW
$3.32B
| $928K | ﹤0.01% |
83,092
-11,368
| -12% | -$111K |
|
2037
ImmunityBio
IBRX
$8.2B
| $926K | ﹤0.01% |
165,121
-26,281
| -14% | -$161K |
|
2038
OFG Bancorp
OFG
$2.26B
| $924K | ﹤0.01% |
34,675
+1,023
| +3% | +$28.4K |
|
|
VIVO
2039
DELISTED
Meridian Bioscience Inc
VIVO
| $924K | ﹤0.01% |
35,610
+2,302
| +7% | +$54.8K |
|
2040
Sally Beauty Holdings
SBH
$1.55B
| $922K | ﹤0.01% |
59,010
-327
| -0.6% | -$5.66K |
|
2041
California Resources
CRC
$4.69B
| $915K | ﹤0.01% |
20,452
+3,746
| +22% | +$161K |
|
2042
Ligand Pharmaceuticals
LGND
$5.76B
| $914K | ﹤0.01% |
13,029
+1,003
| +8% | +$72.8K |
|
2043
QCR Holdings
QCRH
$1.73B
| $908K | ﹤0.01% |
+16,045
| New | +$916K |
|
2044
ArcBest
ARCB
$3.14B
| $904K | ﹤0.01% |
11,234
+518
| +5% | +$46.7K |
|
2045
Forrester Research
FORR
$220M
| $902K | ﹤0.01% |
15,984
+241
| +2% | +$13K |
|
|
HEES
2046
DELISTED
H&E Equipment Services
HEES
| $902K | ﹤0.01% |
20,723
-1,362
| -6% | -$57.3K |
|
2047
Cardlytics
CDLX
$24.7M
| $901K | ﹤0.01% |
1,640
+110
| +7% | +$66.5K |
|
2048
RE/MAX Holdings
RMAX
$263M
| $899K | ﹤0.01% |
32,436
+7
| +0% | +$206 |
|
2049
The GEO Group
GEO
$4.14B
| $892K | ﹤0.01% |
134,976
+2,703
| +2% | +$17.7K |
|
2050
Domo
DOMO
$184M
| $891K | ﹤0.01% |
17,619
+2,199
| +14% | +$99.9K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.